NCT00436293
- Conditions
- Head and Neck Neoplasms, Nasopharyngeal Diseases, Nasopharyngeal Neoplasms, +7 more
- Locations
-
- Sanofi-Aventis Hong Kong
Clinical trial condition
Nasopharyngeal Neoplasms
Explore clinical trials studying Nasopharyngeal Neoplasms. Study availability and eligibility vary by location and protocol.
146 public trials
28 recruiting studies
Nasopharyngeal Neoplasms trial results
NCT00123864
- Conditions
- Carcinoma, Head and Neck Neoplasms, Nasopharyngeal Carcinoma, +11 more
- Locations
-
- Cross Cancer Institute Edmonton, Alberta, Canada
NCT00002901
- Conditions
- Adnexal Diseases, Breast Cancer, Breast Diseases, +54 more
- Locations
-
- Cancer Center and Beckman Research Institute, City of Hope Duarte, California, United States
- USC/Norris Comprehensive Cancer Center and Hospital Los Angeles, California, United States
- University of California Davis Cancer Center Sacramento, California, United States
NCT00006361
- Conditions
- Carcinoma, Carcinoma of Unknown Primary, Carcinoma, Squamous Cell, +23 more
- Locations
-
- Memorial Sloan-Kettering Cancer Center New York, United States
Completed
Gemcitabine and Oxaliplatin (GEMOX) in First Line Metastatic or Recurrent Nasopharyngeal Carcinoma
NCT00436800
- Conditions
- Head and Neck Neoplasms, Nasopharyngeal Diseases, Nasopharyngeal Neoplasms, +7 more
- Locations
-
- Sanofi-Aventis Administrative Office Hong Kong
NCT00078494
- Conditions
- Head and Neck Neoplasms, Nasopharyngeal Diseases, Nasopharyngeal Neoplasms, +7 more
- Locations
-
- National Institutes of Health Clinical Center (CC) Bethesda, Maryland, United States